www.fdanews.com/articles/204459-microbios-covid-19-test-gains-ce-mark
![Microbio Logo](https://www.fdanews.com/ext/resources/test/Device_Images6/Microbio-Logo.png?t=1631924883&width=430)
Microbio’s COVID-19 Test Gains CE Mark
September 20, 2021
Australian diagnostics developer Microbio has earned CE mark certification for its InfectID-COVID-19 tests.
The company, which is located at the Queensland Translational Research Institute in Brisbane, said the detection tests have undergone trials in Australia, the UK and Italy, as well as in the U.S. and India.
The InfectID-COVID-19 tests target regions of the genome of the SARS-CoV-2 coronavirus that are considered unlikely to change, so they will be able to identify new variants that emerge in the pandemic.